Skip to content
Search

Latest Stories

Christie & Co to manage sale of 44 Boots pharmacies

Boots UK has confirmed the sale of 44 pharmacies located across England and Wales and has appointed specialist property adviser Christie & Co to manage the sale.

This is part of the high street chain’s plan to consolidate or close a total of 200 pharmacies by the end of 2020.


Tracey Clements, Chief Operating Officer, Boots UK said, “We very much hope that these pharmacies continue to grow under new ownership. We are sure they will provide a fantastic opportunity for talented pharmacists to create a great local business.”

“The decision to sell or close a pharmacy is never easy, but we are continuing to invest in our wider store network by making our retail, pharmacy and online offer even more differentiated and personalised, with the best brands at the best value,” Clements said.

All sales are planned by May 2020 and the pharma chain called on “first-time buyers and independent pharmacists to buy a pharmacy previously run by Boots”.

“We are delighted to have been appointed by Boots UK to market 44 pharmacies by way of asset sales," said Tony Evans, Head of Pharmacy at Christie & Co.

"With dispensing volumes varying from 1,100 to in excess of 9,000 items per month, the pharmacies occupy either community, high street or health centre environments. The pharmacies offer a tremendous opportunity for first-time buyers and existing independent contractors, as well as regional multiple operators, to acquire corporately-owned pharmacies that are rarely available on the open market, as a result of which we anticipate that strong interest will be generated,” Evans added.

In its fiscal 2020 first-quarter results, Walgreens Boots Alliance (WBA), the parent company of Boots UK, again reported a decline in profits and confirmed the closure of 28 pharmacies.

More For You

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less
Community Pharmacies advised to reduce opening hours and services

Community Pharmacies advised to reduce opening hours and services

Breaking news: Pharmacies advised to reduce opening hours and services from April 1st

The government has been warned that community pharmacies will take collective action and reduce opening hours and services from April 1st unless there is an imminent clarity on a new funding contract.

The National Pharmacy Association (NPA) on Tuesday (17) announced that will advise its 6000 member pharmacies in England to take the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

Keep ReadingShow less
More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

Weight-loss injections can cause gallstones, warns pharmacist

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.

Keep ReadingShow less